Crews Bank & Trust »

Acrivon Therapeutics shares owned by Crews Bank & Trust

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Crews Bank & Trust from 13F filings

Historical chart of Crews Bank & Trust investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Crews Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Crews Bank & Trust

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9k 1.0k 1.78

More positions owned by Crews Bank & Trust

SPDR DJ Wilshire Large Cap (SPYM)
Vanguard Dividend Appreciation ETF (VIG)
Ishares Tr 0-5yr invt gr cp (SLQD)
Vanguard High Dividend Yield ETF (VYM)
Vanguard Growth ETF (VUG)
SPDR Barclay Cp Intr Trm Cr Bd (SPIB)
Spdr Ser Tr spdr russel 2000 (SPSM)
SPDR DJ Wilshire Mid Cap (SPMD)
Apple (AAPL)
Vanguard Intermediate Tm Cpte Bd ETF (VCIT)
Invesco S&p 500 Equal Weight Etf (RSP)
Ishares Inc cmn (EUSA)
Technology SPDR (XLK)
Vanguard Short-Term Bond ETF (BSV)
Microsoft Corporation (MSFT)

View all positions for Crews Bank & Trust

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Acadian Asset Management
Vanguard Capital Management
Wellington Management Company
Renaissance Technologies
Two Sigma Investments
Marshall Wace
Bridgeway Capital Management
Geode Capital Management
BlackRock
GSA Capital Partners
Vanguard Fiduciary Trust
XTX Topco
Jane Street

View all funds holding Acrivon Therapeutics